Department of Respiratory Medicine OE6870, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
Respir Med. 2009 May;103(5):743-9. doi: 10.1016/j.rmed.2008.11.015. Epub 2008 Dec 30.
Bronchiolitis obliterans syndrome (BOS) represents the leading cause of late mortality after lung transplantation (LTx). Cystic fibrosis (CF) patients frequently show airway colonization with gram-negative bacteria (GNB) both before and after LTx. Graft colonization with GNB and its relevance towards BOS development were investigated in a CF population after LTx. Adult CF patients receiving LTx and surviving at least 6 months were included in this prospective observational study between 1/1/2002 and 30/6/2006 in a single center and followed until 31/3/2007. Pre- and post-LTx respiratory culture samples were compared for the presence of identical GNB. BOS-free survival was compared in colonized and non-colonized patients. Fifty-nine adult CF patients with a median age at LTx of 25.5 (18-49) years were included and had a median follow-up of 966 (128-1889) days. Seven patients (15%) demonstrated immediate eradication of GNB in lower respiratory tract samples. A further 18 patients (34%) demonstrated transient colonization. Thirty-four recipients had further positive samples after LTx. Eighteen patients (31%) developed BOS >or=stage 1, 508 (114-1167) days after LTx. Freedom of graft colonization with pseudomonads was independently associated with less frequent development of BOS (p=0.006). Persistent graft colonization with pseudomonads increases the prevalence of BOS after LTx in CF patients. A significant proportion of post-LTx CF patients demonstrates subsequent GNB eradication during later follow-up and this may have a protective role against development of BOS. Strategies to eradicate airway colonization or reduce bacterial load may prevent BOS in CF patients after LTx.
闭塞性细支气管炎综合征(BOS)是肺移植(LTx)后晚期死亡的主要原因。囊性纤维化(CF)患者在 LTx 前后经常表现出气道革兰氏阴性菌(GNB)定植。在 LTx 后的 CF 人群中,研究了 GNB 移植物定植及其与 BOS 发展的相关性。本前瞻性观察研究纳入了 2002 年 1 月 1 日至 2006 年 6 月 30 日在单中心接受 LTx 并至少存活 6 个月的成年 CF 患者,并随访至 2007 年 3 月 31 日。比较了 LTx 前后呼吸培养样本中相同 GNB 的存在情况。比较了定植和非定植患者的 BOS 无进展生存率。共纳入 59 例中位年龄为 25.5(18-49)岁的成年 CF 患者,中位随访时间为 966(128-1889)天。7 例(15%)患者在下呼吸道样本中立即消除了 GNB。进一步有 18 例(34%)患者出现一过性定植。34 例患者在 LTx 后出现进一步的阳性样本。18 例(31%)患者发生 BOS≥1 期,LTx 后 508(114-1167)天。移植物定植假单胞菌与 BOS 发生率降低独立相关(p=0.006)。CF 患者 LTx 后移植物定植持续假单胞菌增加 BOS 的患病率。在随后的随访中,LTx 后 CF 患者的很大一部分患者随后消除了 GNB,这可能对预防 BOS 发展具有保护作用。消除气道定植或降低细菌负荷的策略可能会预防 CF 患者 LTx 后的 BOS。